Drug intelligence / Profile preview

Lactobacillus paracasei PC646

Development stage: Unknown
Modality: Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
Administration: Oral

Overview

Lactobacillus paracasei PC646 is a specific strain of the probiotic bacterium L. paracasei, isolated from fermented dairy products. This strain has been identified for its broad-spectrum antibacterial activity and potential health benefits, particularly in oral health applications. Probiotics like L. paracasei are known to help maintain healthy microbial balance by inhibiting pathogenic bacteria, supporting immune function, and possibly reducing inflammation. The PC646 strain is currently being studied for its effects on halitosis (bad breath), oral flora composition, and oral inflammation in patients with periodontal disease[7][10]. Its mechanism of action likely involves competitive inhibition of harmful bacteria and modulation of local immune responses.

Other names: Lacticaseibacillus paracasei PC646

Beyond the preview

Go deeper on Lactobacillus paracasei PC646.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lactobacillus paracasei PC646.

Explore the full profile